SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-506020
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
3
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2042317z10-k.txt 10-K 189810
2 EXHIBIT 10.33 a2042317zex-10_33.txt EX-10.33 8021
3 EXHIBIT 23.2 a2042317zex-23_2.txt EX-23.2 838
  Complete submission text file 0000912057-01-506020.txt   200410
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 1589056
SIC: 2836 Biological Products, (No Diagnostic Substances)